Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
Humacyte priced a public offering of 47.6 million shares at $1.05 per share, generating gross proceeds of $50 million. The company granted underwriters a 30-day option to purchase up to 7.1 million additional shares at the same price.
Key figures
- Deal Value Usd
- 50000000
- Offering Price
- 1.05
- Shares Offered
- 47619048
- Overallotment shares
- 7142857
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.